DCD肝移植供肝质量评估进展文献综述
The Literature Review of Progress in Quality Assessment for Donation-after-Cardiac-Death Liver Transplantation
DOI: 10.12677/ACM.2018.82043, PDF,   
作者: 司铮先, 刘宝志, 陈永林, 张升宁：昆明医科大学附属甘美医院肝胆胰一科，云南 昆明；冯婧星：昆明医科大学第二附属医院肝胆胰二科，云南 昆明
关键词: DCD肝移植；DCD供肝质量；脂肪肝；冷–热缺血时间；危险因素；Donation-after-Cardiac-Death Liver Transplantation； Quality of DCD Liver； Liver Steatosis； Cold-Warm Ischemia Time； Risk Factors
摘要: 1963年美国医师Starzl实施了全球首例人体原位肝移植手术，此后随着肝移植外科技术的改进、免疫抑制方案的优化以及移植后病人管理的进步，肝移植成为终末期肝病的最佳治疗手段。然而供肝资源短缺制约了肝移植的进一步发展。近年来心脏死亡器官捐献(DCD)供肝在肝移植手术中的应用，有效扩大了供肝池，并已经得到世界卫生组织认可在全世界范围内实行。DCD供肝作为扩大选择标准的供肝来源，准确评估其质量并确保移植后受体的生存率，是国内外器官移植领域的研究热点。本文就DCD供肝质量评估最新进展作一综述。
Abstract: The American surgeon Thomas Starzl performed the first human liver transplantation surgery in human history in 1963. Then improvements in surgical techniques, immunosuppression, and post-transplantation patient care have led to the optimization of liver transplantation outcomes. However, the scarcity of donor liver restricts further development of liver transplantation. In recent years, the use of donation after cardiac death (DCD) liver effectively expands the donor pool and has been accepted by the WHO. There are so many researches focusing on how to effectively assess the quality of DCD liver in order to ensure the survival rate after transplantation. The present essay reviews the latest developments in this field.
文章引用：司铮先, 冯婧星, 刘宝志, 陈永林, 张升宁. DCD肝移植供肝质量评估进展文献综述[J]. 临床医学进展, 2018, 8(2): 253-258. https://doi.org/10.12677/ACM.2018.82043

参考文献

[1] Saidi, R.F. (2012) Current Status of Liver Transplantation. Archives of Iranian Medicine, 15, 772-776.
[2] Lacaille, F. (2012) Liver Transplantation and Liver Cell Transplantation. Clinics and Research in Hepatology and Gastroenterology, 36, 304-307.
[Google Scholar] [CrossRef] [PubMed]
[3] Atria, M., Silva, M.A. and Mirza, D.F. (2008) The Marginal Liver Donor—An Update. Transplant International, 21, 713-724.
[Google Scholar] [CrossRef] [PubMed]
[4] Nadig, S.N., Bratton, C.F. and Karp, S.J. (2007) Marginal Donors in Liver Transplantation: Expanding the Donor Pool. Journal of Surgical Education, 64, 46-50.
[Google Scholar] [CrossRef] [PubMed]
[5] Sherlock, S. (1983) Acute Fatty Liver of Pregnancy and the Microvesicular Fat Diseases. Gut, 24, 265-269.
[Google Scholar] [CrossRef] [PubMed]
[6] Selzner, M. and Clavien, P.A. (2001) Fatty Liver in Liver Transplanta-tion and Surgery. Seminars in Liver Disease, 21, 105-114.
[Google Scholar] [CrossRef] [PubMed]
[7] Briceno, J., Solórzano, G. and Pera, C. (2000) A Proposal for Scoring Marginal Liver Grafts. Transplant International, 13, S249-S252.
[Google Scholar] [CrossRef] [PubMed]
[8] Imber, C.J., St. Peter, S.D., Handa, A., et al. (2002) Hepatic Steatosis and Its Relationship to Transplantation. Liver Transplantation, 8, 415-423.
[Google Scholar] [CrossRef] [PubMed]
[9] Adam, R., Reynes, M., Johann, M., et al. (1991) The Outcome of Steatotic Grafts in Liver Transplantation. Transplantation Proceedings, 23, 1538-1540.
[10] Spitzer, A.L., Lao, O.B., Dick, A.A., et al. (2010) The Biopsied Donor Liver, Incorporating Macrosteatosis into High-Risk Donor Assessment. Liver Transplantation, 16, 874-884.
[Google Scholar] [CrossRef] [PubMed]
[11] Fishbein, T.M., Fiel, M.I., Emre, S., et al. (1997) Use of Livers with Microvessicular Fat Safely Expands the Donor Pool. Transplantation, 64, 248-251.
[Google Scholar] [CrossRef] [PubMed]
[12] Strasberg, S.M., Howard, T.K., Molmenti, E.P., et al. (1994) Selecting the Donor Liver: Risk Factors for Poor Function after Orthotopic Liver Transplantation. Hepatology, 20, 829-838.
[Google Scholar] [CrossRef] [PubMed]
[13] Loinaz, C. and Gonzlez, E.M. (2000) Marginal Donors in Liver Transplantation. Hepatogastroenterology, 47, 256-263.
[14] Perera, M.T. and Bramhall, S.R. (2011) Current Status and Recent Advances of Liver Transplantation from Donation after Cardiac Death. World Journal of Gastrointestinal Surgery, 3, 167-176.
[Google Scholar] [CrossRef] [PubMed]
[15] Lee, K.W., Simpkins, C.E., Montgomery, R.A., et al. (2006) Factors Affecting Graft Survival after Liver Transplantation from Donation after Car-diac Death Donors. Transplantation, 82, 1683-1688.
[Google Scholar] [CrossRef] [PubMed]
[16] Abt, P.L., Praestgaard, J., West, S., et al. (2014) Donor Hemodynamic Profile Presages Graft Survival in Donation after Cardiac Death Liver Transplantation. Liver Trans-plantation, 20, 165-172.
[Google Scholar] [CrossRef] [PubMed]
[17] Totsuka, E., Fung, J., Lee, M., Ishi, T., Umehara, M., et al. (2002) Influence of Cold Ischemia Time and Graft Transport Distance on Postoperative Outcome in Human Liver Transplantation. Surgery Today, 32, 792-799.
[Google Scholar] [CrossRef] [PubMed]
[18] Nguyen, J.H., Bonatti, H., Dickson, R.C., et al. (2009) Long-Term Outcomes of Donation after Cardiac Death Liver Allografts from a Single Center. Clinical Transplantation, 23, 168-173.
[Google Scholar] [CrossRef] [PubMed]
[19] Fernandez-Merino, F.J., Nuno-Garza, J., Lopez-Hervas, P., et al. (2003) Donor Age as a Risk Factor for Patient Survival in the Liver Transplant. Transplantation Proceedings, 35, 1795-1797.
[Google Scholar] [CrossRef] 
[20] Detry, O., Derover, A., Meurisse, N., et al. (2014) Donor Age as a Risk Factor in Donation after Circulatory Death Liver Transplantation in a Controlled Withdrawal Protocol Programme. British Journal of Surgery, 101, 784-792.
[Google Scholar] [CrossRef] [PubMed]
[21] Loggi, E., Micco, L., Ercolani, G., et al. (2012) Liver Transplantation from Hepatitis B Surface Antigen Positive Donors: A Safe Way to Expand the Donor Pool. Journal of Hepatology, 56, 579-585.
[Google Scholar] [CrossRef] [PubMed]
[22] Testa, G., Goldstein, R.M., Netto, G., et al. (1998) Long-Term Outcome of Patients Transplanted with Livers from Hepatitis C-Positive Donors. Transplantation, 65, 925-929.
[Google Scholar] [CrossRef] [PubMed]
[23] Briceno, J., Marchal, T., Padillo, J., et al. (2002) In-fluence of Marginal Donors on Liver Preservation Injury. Transplantation, 74, 522-526.
[Google Scholar] [CrossRef] [PubMed]
[24] Saab, S., Chang, A.J., Comulada, S., et al. (2003) Outcomes of Hepatitis C and Hepatitis B Core Antibody-Positive Grafts in Orthotopic Liver Transplantation. Liver Transplantation, 9, 1053-1061.
[Google Scholar] [CrossRef] [PubMed]
[25] Mangus, R.S., Fridell, J.A., Vianna, R.M., et al. (2010) Severe Hy-pernatremia in Deceased Liver Donors Doas Not Impact Earl Transplant Outcome. Transplantation, 90, 438-443.
[Google Scholar] [CrossRef] 
[26] 刘现忠, 王轩. 边缘性供肝对肝移植术后肝功能影响及对策[J]. 中国普通外科杂志, 2010, 19(7): 809-812.
[27] Kauffman, H.M., Cherikh, W.S., McBride, M.A., et al. (2007) Deceased Donors with a Past History of Malignancy: An Organ Procurement and Transplantation Network/United Network for Organ Sharing Update. Transplantation, 84, 272-274.
[Google Scholar] [CrossRef] [PubMed]
[28] Goldaracena, N., Qui onez, E., M dez, P., et al. (2012) Extremely Marginal Liver Grafts from Deceased Donors Have Outcome Similar to Ideal Grafts. Transplantation Pro-ceedings, 44, 2219-2222.
[Google Scholar] [CrossRef] [PubMed]
[29] Cameron, A. and Busuttil, R.W. (2005) AASLD/ILTS Transplant Course: Is There an Extended Donor Suitable for Everyone? Liver Transplantation, 11, S2-S5.
[Google Scholar] [CrossRef] [PubMed]
[30] Adam, R., Reynes, M., Bao, Y., et al. (1993) Impact of Glycogen Content of the Donor Liver in Clinical Liver Transplantation. Transplantation Proceedings, 25, 1536-1537.
[31] Olmedilla, L., Lisbona, C.J., Pérez-Peña, J.M., et al. (2016) Early Measurement of Indocyanine Green C1earance Accurately Predicts Short-Term Outcomes after Liver Transplantation. Transplantation, 100, 613-620.
[Google Scholar] [CrossRef] 

为你推荐